FR2536998B1 - Composition contenant des composes marques par la radioactivite, stabilises par des diethylenetriamines thiocarbonylees - Google Patents

Composition contenant des composes marques par la radioactivite, stabilises par des diethylenetriamines thiocarbonylees

Info

Publication number
FR2536998B1
FR2536998B1 FR8311521A FR8311521A FR2536998B1 FR 2536998 B1 FR2536998 B1 FR 2536998B1 FR 8311521 A FR8311521 A FR 8311521A FR 8311521 A FR8311521 A FR 8311521A FR 2536998 B1 FR2536998 B1 FR 2536998B1
Authority
FR
France
Prior art keywords
thiocarbonylated
diethylenetriamines
composition containing
containing radioactivity
marked compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8311521A
Other languages
English (en)
Other versions
FR2536998A1 (fr
Inventor
Nathan Tzodikov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lantheus Medical Imaging Inc
Original Assignee
New England Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Nuclear Corp filed Critical New England Nuclear Corp
Publication of FR2536998A1 publication Critical patent/FR2536998A1/fr
Application granted granted Critical
Publication of FR2536998B1 publication Critical patent/FR2536998B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8311521A 1982-07-12 1983-07-11 Composition contenant des composes marques par la radioactivite, stabilises par des diethylenetriamines thiocarbonylees Expired FR2536998B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/397,501 US4411881A (en) 1982-07-12 1982-07-12 Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines

Publications (2)

Publication Number Publication Date
FR2536998A1 FR2536998A1 (fr) 1984-06-08
FR2536998B1 true FR2536998B1 (fr) 1988-01-22

Family

ID=23571454

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8311521A Expired FR2536998B1 (fr) 1982-07-12 1983-07-11 Composition contenant des composes marques par la radioactivite, stabilises par des diethylenetriamines thiocarbonylees

Country Status (7)

Country Link
US (1) US4411881A (fr)
JP (1) JPS5924257A (fr)
CA (1) CA1205070A (fr)
CH (1) CH655853A5 (fr)
DE (1) DE3324593C2 (fr)
FR (1) FR2536998B1 (fr)
GB (1) GB2123412B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331159A1 (de) * 1983-08-30 1985-03-14 Hoechst Ag, 6230 Frankfurt N-(4-aminobenzoyl)-aminodicarbonsaeuren zur stabilisierung von technetium-99m-praeparaten, stabilisierte injektionspraeparate und verfahren zu ihrer herstellung
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
JPH0317229U (fr) * 1989-06-30 1991-02-20
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
WO1992010214A1 (fr) * 1990-12-12 1992-06-25 Mallinckrodt Medical, Inc. Procede de marquage isotopique de cellules du sang et kit pour ce faire
AU2541592A (en) * 1991-08-01 1993-03-02 Hybritech Incorporated Improvements in or relating to modified haptens useful as imaging and therapeutic agents
JP3117719B2 (ja) * 1992-04-30 2000-12-18 アマーシャム・インターナショナル・ピーエルシー 放射性標識化合物の配合物
US5686058A (en) * 1992-04-30 1997-11-11 Amersham International Plc Radiolabelled nucleotide formulations stored in an unfrozen state
US5342926A (en) * 1993-06-08 1994-08-30 The Regents Of The University Of California Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport
WO1997001520A1 (fr) * 1995-06-28 1997-01-16 E.I. Du Pont De Nemours And Company Composition et procede de stabilisation de composes organiques radiomarques
EP0971747B1 (fr) * 1996-10-28 2005-12-28 Amersham Health AS Agents de contraste
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
HUP0101921A2 (hu) * 2001-05-10 2004-01-28 Izotóp Intézet Kft Radioaktívan jelzett nukleotido/ka/t tartalmazó preparátumok és eljárás azok előállítására
CN100418585C (zh) * 2003-07-24 2008-09-17 伯拉考成像股份公司 稳定的放射性药物组合物及制备方法
US11474106B2 (en) 2015-07-08 2022-10-18 Lawrence Livermore National Security, Llc Methods for cytotoxic chemotherapy-based predictive assays
WO2018132766A1 (fr) * 2017-01-12 2018-07-19 The Regents Of The University Of California Dosages prédictifs basés sur une chimiothérapie cytotoxique pour la leucémie myéloïde aiguë

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919095A (en) * 1973-07-30 1975-11-11 Mobil Oil Corp Organic compositions containing antioxidant and antiwear additives
US3876550A (en) * 1974-04-15 1975-04-08 Lubrizol Corp Lubricant compositions
US4358434A (en) * 1979-12-19 1982-11-09 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds

Also Published As

Publication number Publication date
JPS5924257A (ja) 1984-02-07
JPH0211105B2 (fr) 1990-03-12
FR2536998A1 (fr) 1984-06-08
GB2123412A (en) 1984-02-01
GB8316714D0 (en) 1983-07-20
US4411881A (en) 1983-10-25
GB2123412B (en) 1986-03-05
CA1205070A (fr) 1986-05-27
CH655853A5 (de) 1986-05-30
DE3324593C2 (de) 1986-10-23
DE3324593A1 (de) 1984-02-02

Similar Documents

Publication Publication Date Title
FR2536998B1 (fr) Composition contenant des composes marques par la radioactivite, stabilises par des diethylenetriamines thiocarbonylees
IT1170387B (it) Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
MA19823A1 (fr) Composition de blanchiment .
IT1169771B (it) Composizione per agenti antitumorali
NL188473B (nl) Polycarbonaat bevattende, thermoplastische vormsamenstelling.
IT8323634A0 (it) Composizione per fotoriproduzioni.
DE3583334D1 (de) Borverbindungen enthaltende polycarbonatzusammensetzungen.
DE3784566D1 (de) Bisphenolverbindungen enthaltende zusammensetzungen.
NL8300934A (nl) Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
GB2096889B (en) Pharmaceutical composition containing 6-amino-1-hydroxyhexane-1,1-diphosphonic acid
IL70520A0 (en) Substituted phenyl sulfonyloxybenzimidazole-carbamates,process for their preparation and pharmaceutical compositions containing the same
BR8301838A (pt) Composicao antioxidante hidroliticamente estavel
DK597284D0 (da) Antioxidantkomposition
RO89717A (fr) Composition herbicide liquide
NL188654B (nl) Polycarbonaat bevattende, thermoplastische vormsamenstelling.
DE3381943D1 (de) Bakterizide zusammensetzung.
ATA164083A (de) Gewebeweichmachende zusammensetzung
GB2055042B (en) Pharmaceutical compositions containing substituted biruets compound
IT1194224B (it) Derivati di cicloalcani,procedimento per la loro preparazione e composizioni che li contengono
IT8322665A0 (it) Procedimento per preparare composizioni contenenti gammaglobulina.
DE3381646D1 (de) Thermochrom-zusammensetzung.
IT1170361B (it) Cianoguanidine, procedimento per ottenerle e composizioni farmaceutiche che le contengono
IL70273A (en) N-(substituted alkyl)acridanone-2-thiazole-2-yl-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them
IT1233243B (it) Derivati dell'isochinolina.
IT1213208B (it) Composizioni iniettabili,contenenti metronidazolo

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property